ERBB3 and cancer: These results suggest that S. flexneri C.11 may drive the inflammation-to-cancer transition through the activation of the ERBB3 pathway in early carcinogenesis, while during tumor progression, the sustained activity of this pathway may be maintained by the interplay between the bacterial and host microenvironment.